Passiglia, Francesco
Cappuzzo, Federico
Alabiso, Oscar
Bettini, Anna Cecilia
Bidoli, Paolo
Chiari, Rita
Defferrari, Carlotta
Delmonte, Angelo
Finocchiaro, Giovanna
Francini, Guido
Gelsomino, Francesco
Giannarelli, Diana
Giordano, Monica
Illiano, Alfonso
Livi, Lorenzo
Martelli, Olga
Natoli, Clara
Puppo, Gianfranco
Ricevuto, Enrico
Roca, Elisa
Turci, Daniele
Galetta, Domenico
Article History
Received: 12 May 2018
Revised: 12 July 2018
Accepted: 26 July 2018
First Online: 31 October 2018
Competing interests
: F.C. was a consultant for BMS, AZ, Roche, MSD and Pfizer; D.G. was a consultant for BMS; the remaining authors declare no competing interests.
: The trial protocol was previously approved by the Local Independent Ethics Committee and all the patients provided a written informed consent before enrolment. The study was conducted in accordance with the Declaration of Helsinki.
: All the data analysed supporting the results reported in the article may be found/ are archived at the Biostatistics Unit, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).